FORA

Forian Inc

Add to Watchlist

Advanced Chart

1.970

+0.04(2.073%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

2.0099

Open

1.980

VWAP

1.94

Vol

21.28K

Mkt Cap

61.47M

Low

1.930

Amount

41.37K

EV/EBITDA(TTM)

Total Shares

31.14M

31.30M

EV/OCF(TTM)

10.65

P/S(TTM)

2.69

Forian Inc. is a healthtech company. The Company is a provider of data science-driven information and analytics solutions to the life science, healthcare and financial services industries. The Company provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure the operational, clinical and financial performance of customers. It has expertise in acquiring, integrating, normalizing and commercializing large-scale healthcare data assets. Its data ingestion, transformation, delivery services and business intelligence platforms are managed entirely via cloud-based data centers located in the United States. The Company’s offerings include commercial, Real World Evidence (RWE) and market access solutions and proprietary data-driven insights to optimize the operational, clinical and financial performance of its customers. The Company’s solutions include CHRONOS, Chartis, RWE and Kyber Data Science.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

FY2025Q2

7.41M

+27.5%

7.26M

+55%

7.17M

+50.01%

Estimates Revision

The market is revising No Change the revenue expectations for Forian Inc. (FORA) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 4.78%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Up

+4.78%

In Past 3 Month

1 Analyst Rating

153.81% Upside

Wall Street analysts forecast FORA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FORA is 5.00 USD with a low forecast of 5.00 USD and a high forecast of 5.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

153.81% Upside

Current: 1.970

Low

5.00

Averages

5.00

High

5.00

153.81% Upside

Current: 1.970

Low

5.00

Averages

5.00

High

5.00

Roth MKM

Richard Baldry

Strong Buy

Reiterates

2024-11-14

Reason

Roth MKM

Richard Baldry

Price Target

2024-11-14

Reiterates

Strong Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Forian Inc (FORA.O) is -12.06, compared to its 5-year average forward P/E of -10.99. For a more detailed relative valuation and DCF analysis to assess Forian Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-10.99

Current PE

-12.06

Overvalued PE

11.79

Undervalued PE

-33.76

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

71.15

Current EV/EBITDA

41.38

Overvalued EV/EBITDA

183.96

Undervalued EV/EBITDA

-41.66

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

3.34

Current PS

2.10

Overvalued PS

5.50

Undervalued PS

1.19